Brian Woolhouse, VP and General Manager, Hospital Acute Care at Merck
joined us for World Anti-Microbial Resistance Congress USA 2015 to discuss
'Merck's Commitment to Infectious Diseases: The Commercialization Challenges of New Antibiotics'
.
In this presentation, learn about
Merck's commitment to innovation and leadership in infectious diseases
.
Download the presentation to understand more about:
-
How Merck is actively addressing the unmet need
-
Merck's focus on antibiotic innovation and discovery across many of the most urgent threats
-
Launching Novel IV antibiotics
...and
much
more!
Get your copy here!
To find out more about
the commercialization challenges of new antibiotics
, attend
World Anti-Microbial Resistance Congress USA 2016
held
September 8-9
in
Washington, DC
.